Caris Life Sciences, Inc. (CAI)
NASDAQ: CAI · Real-Time Price · USD
15.79
+0.23 (1.48%)
Jul 21, 2026, 1:09 PM EDT - Market open
Caris Life Sciences Market Cap
Caris Life Sciences has a market cap or net worth of $4.46 billion as of July 21, 2026. Its market cap has decreased by -48.85% in one year.
Market Cap
4.46B
Enterprise Value
4.01B
1-Year Change
-48.85%
Ranking
Category
Stock Price
$15.79
ChartMarket Cap Chart
Since the IPO on June 18, 2025, Caris Life Sciences's market cap has decreased from $5.95B to $4.46B, a decrease of -25.04%. That is a compound annual growth rate of -23.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 4.66B | -38.77% |
| Dec 31, 2025 | 7.61B | 27.84% |
| Jun 18, 2025 | 5.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Travere Therapeutics | 5.27B |
| CRISPR Therapeutics AG | 4.71B |
| Veradermics | 4.65B |
| ACADIA Pharmaceuticals | 4.38B |
| Relay Therapeutics | 4.34B |
| Celcuity | 4.31B |
| Legend Biotech | 4.31B |
| Viking Therapeutics | 4.31B |